Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data

Published:2019-01 Issue: Volume:133 Page:58-73
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Chartron Elodie^ORCID,Theillet Charles,Guiu Séverine,Jacot William

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference168 articles.

1. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers;Watkins;Breast Cancer Res.,2014

2. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer;Abkevich;Br. J. Cancer,2012

3. Somatic mutations in homologous recombination pathway genes in ovarian cancer;Aghajanian;J. Clin. Oncol.,2017

4. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group;Alsop;J. Clin. Oncol.,2012

5. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am. J. Hum. Genet.,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer;BMC Biology;2024-04-16

2. Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype;Discover Oncology;2024-01-16

3. Next-Generation Therapies for Breast Cancer;Smart Nanomaterials Technology;2024

4. The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489;Cells;2023-12-26

5. Combination Treatment Strategies to Overcome PARP Inhibitor Resistance;Biomolecules;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3